Livingston Group Asset Management CO operating as Southport Capital Management Acquires 301 Shares of Humana Inc (NYSE:HUM)

Share on StockTwits

Livingston Group Asset Management CO operating as Southport Capital Management lifted its holdings in Humana Inc (NYSE:HUM) by 14.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,407 shares of the insurance provider’s stock after acquiring an additional 301 shares during the period. Livingston Group Asset Management CO operating as Southport Capital Management’s holdings in Humana were worth $882,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in HUM. Endurance Wealth Management Inc. boosted its holdings in Humana by 354.5% in the third quarter. Endurance Wealth Management Inc. now owns 100 shares of the insurance provider’s stock worth $26,000 after acquiring an additional 78 shares in the last quarter. Evoke Wealth LLC bought a new position in shares of Humana in the 3rd quarter worth $26,000. Quest Capital Management Inc. ADV bought a new stake in Humana during the 3rd quarter valued at $30,000. Penserra Capital Management LLC bought a new stake in Humana during the 3rd quarter valued at $31,000. Finally, Psagot Investment House Ltd. bought a new stake in Humana during the 3rd quarter valued at $35,000. 94.59% of the stock is currently owned by institutional investors.

In other news, insider Elizabeth D. Bierbower sold 400 shares of Humana stock in a transaction on Monday, December 16th. The stock was sold at an average price of $370.00, for a total transaction of $148,000.00. Following the sale, the insider now directly owns 21,985 shares in the company, valued at approximately $8,134,450. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Elizabeth D. Bierbower sold 5,347 shares of Humana stock in a transaction on Wednesday, December 18th. The stock was sold at an average price of $370.00, for a total value of $1,978,390.00. Following the sale, the insider now owns 23,439 shares in the company, valued at $8,672,430. The disclosure for this sale can be found here. Insiders have sold a total of 45,294 shares of company stock worth $15,894,412 over the last quarter. Company insiders own 0.54% of the company’s stock.

A number of research analysts have weighed in on HUM shares. Credit Suisse Group raised their price objective on shares of Humana from $378.00 to $400.00 and gave the company an “outperform” rating in a research note on Wednesday, January 8th. JPMorgan Chase & Co. upped their target price on shares of Humana from $437.00 to $448.00 and gave the stock an “overweight” rating in a report on Friday, January 3rd. Barclays raised their price target on shares of Humana from $327.00 to $358.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. BMO Capital Markets downgraded Humana from an “outperform” rating to a “market perform” rating and cut their price target for the company from $345.00 to $290.00 in a research note on Monday, September 30th. Finally, ValuEngine downgraded Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, December 4th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $355.75.

NYSE:HUM traded up $0.69 on Thursday, hitting $364.76. The stock had a trading volume of 156,075 shares, compared to its average volume of 828,475. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.83 and a current ratio of 1.83. The stock has a market cap of $47.31 billion, a P/E ratio of 25.07, a price-to-earnings-growth ratio of 1.38 and a beta of 0.92. Humana Inc has a 1 year low of $225.65 and a 1 year high of $376.39. The firm’s fifty day simple moving average is $358.50 and its two-hundred day simple moving average is $304.25.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, November 6th. The insurance provider reported $5.03 earnings per share for the quarter, topping analysts’ consensus estimates of $4.58 by $0.45. The firm had revenue of $16.24 billion for the quarter, compared to the consensus estimate of $16.15 billion. Humana had a return on equity of 22.32% and a net margin of 4.06%. The company’s revenue was up 14.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $4.58 EPS. Equities research analysts predict that Humana Inc will post 17.77 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.60%. The ex-dividend date of this dividend is Monday, December 30th. Humana’s payout ratio is 15.12%.

Humana Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Recommended Story: What is Liquidity?

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.